-
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. Views are subject to revision over time.
The Norway website is not available. You will be redirected to the Luxembourg website which contains funds approved for marketing in Luxembourg, and where several of these funds are not registered for marketing in Norway.
Norges nettside er ikke tilgjengelig. Du vil bli omdirigert til Luxembourg-nettstedet som inneholder midler godkjent for markedsføring i Luxembourg, og hvor flere av disse fondene ikke er registrert for markedsføring i Norge.
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. Views are subject to revision over time.
MSCI makes no express or implied warranties or representations, and shall have no liability whatsoever with respect to any MSCI data contained herein.
The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed or produced by MSCI.
Eric Winograd is a Senior Vice President and Director of Developed Market Economic Research. He joined the firm in 2017. From 2010 to 2016, Winograd was the senior economist at MKP Capital Management, a US-based diversified alternatives manager. From 2008 to 2010, he was the senior macro strategist at HSBC North America. Earlier in his career, Winograd worked at the Federal Reserve Bank of New York and the World Bank. He holds a BA (cum laude) in Asian studies from Dartmouth College and an MA in international studies from the Paul H. Nitze School of Advanced International Studies. Location: New York
Chris Brigham is a Private Client Senior Research Associate at Bernstein. He joined Bernstein in 2018 as a member of the US Portfolio Strategy team. Prior to Bernstein, he worked in finance and strategy for EpiBone, a biotechnology startup. He has previously worked as a research analyst at Longview Asset Management and Tiresias Capital (Omni Partners) and as an event-driven analyst and trader at Bank of America Merrill Lynch. Chris earned his MBA from Columbia Business School, where he completed the Value Investing Program, and graduated Phi Beta Kappa with a BA in Economics from Claremont McKenna College. He completed the General Course at the London School of Economics and is a CFA charterholder. Location: New York
This is a marketing communication. This information is provided by AllianceBernstein (Luxembourg) S.à r.l. Société à responsabilité limitée, R.C.S. Luxembourg B 34 305, 2-4, rue Eugène Ruppert, L-2453 Luxembourg. Authorised in Luxembourg and regulated by the Commission de Surveillance du Secteur Financier (CSSF). It is provided for informational purposes only and does not constitute investment advice or an invitation to purchase any security or other investment. The views and opinions expressed are based on our internal forecasts and should not be relied upon as an indication of future market performance. The value of investments in any of the Funds can go down as well as up and investors may not get back the full amount invested. Past performance does not guarantee future results.
This information is directed at Professional Clients only and is not intended for public use.